Embo Medical, emanating from the first year of BioInnovate was established by fellows Wayne Allen, Colin Forde and Liam Mullins to develop the first true one-shot vascular embolisation device. Embo Medical raised €3 million in investment to further develop the product towards commercialisation. The investment syndicate included the AIBSeed Capital Fund, Irrus Investments and the Halo Business Angel Network. The venture was also supported by Enterprise Ireland under its high potential start-up fund following an initial Commercialisation Fund award. Embo Medical sold to Bard Clearstream in 2015 for a total of €43.5 million.
- Established: 2012
- Funding: €3 million
- Status: Sold to Bard Clearstream for €35.58 million